Discovery of novel 2, 8-diazaspiro [4.5] decanes as orally active glycoprotein IIb-IIIa antagonists
…, L Nannizzi-Alaimo, GL Park, JL Lambing…
Index: Mehrotra, Mukund M.; Heath, Julie A.; Smyth, Mark S.; Pandey, Anjali; Rose, Jack W.; Seroogy, Joseph M.; Volkots, Deborah L.; Nannizzi-Alaimo, Lisa; Park, Gary L.; Lambing, Joseph L.; Hollenbach, Stanley J.; Scarborough, Robert M. Journal of Medicinal Chemistry, 2004 , vol. 47, # 8 p. 2037 - 2061
Full Text: HTML
Citation Number: 21
Abstract
In our efforts to develop orally active GPIIb-IIIa antagonists with improved pharmaceutical properties, we have utilized a novel 2, 8-diazaspiro [4.5] decane scaffold as a template. We describe here our investigation of a variety of templates including spiropiperidinyl-γ-lactams, spiropiperidinylimide, spiropiperidinylureas, and spiropiperidinylhydantoins. With the appropriate acidic and basic pharmacophores in place, each template yielded analogues ...
Related Articles:
Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity
[Greenwald, Richard B.; Pendri, Annapurna; Conover, Charles D.; Lee, Chyi; Choe, Yun H.; Gilbert, Carl; Martinez, Anthony; Xia, Jing; Wu, Dechun; Hsue, Mei-mann Bioorganic and Medicinal Chemistry, 1998 , vol. 6, # 5 p. 551 - 562]
[Beresford; Macrae; Alker; Kobylecki Arzneimittel-Forschung/Drug Research, 1989 , vol. 39, # 2 p. 201 - 209]